Blackstone Inc. is launching a publicly traded acquisition company that will snap up data centers, giving millions of mom-and-pop investors a chance to bet on the artificial intelligence boom. The ...
A free Minecraft tool called Arnis lets players explore real-world locations, including their own neighborhood, using ...
Blackstone Inc.’s talks with New World Development Co. have hit a roadblock because the billionaire family that runs the cash-strapped Hong Kong developer is reluctant to give up control, people ...
NEW YORK, March 3 (Reuters) - Blackstone's (BX.N), opens new tab flagship private credit fund faced a surge in withdrawals in the first quarter, amid wider investor jitters about private credit and ...
In a filing with the Securities and Exchange Commission, Blackstone Private Credit Fund, commonly known as BCRED, said clients had redeemed close to $3.7 billion in the fund’s shares during the first ...
At the WSJ Live Invest event in February, Blackstone President Jonathan Gray said private credit metrics looked very healthy. Photo: Patrick T. Fallon/AFP/Getty Images Now, the momentum has shifted.
Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk ...
Blackstone Inc. is allowing investors to redeem a record 7.9% of shares from its flagship private credit fund, the latest sign of unease in an industry that’s faced a wave of withdrawals. The firm is ...
Investing.com-- Blackstone Inc’s (NYSE: BX) flagship private credit fund saw $1.7 billion in net outflows in the first quarter amid growing investor uncertainty towards the asset class, a securities ...
Every time Alex publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results